Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease

Running, not enrolling · Not applicable

Conditions studied: Chronic Graft-versus-host Disease, Chronic GVHD, cGVHD

In brief

This research study is evaluating the feasibility and acceptability of implementing a telehealth palliative care intervention in patients with moderate to severe chronic graft-versus-host disease.

Key facts

Study ID

NCT06458127

Run by

Massachusetts General Hospital

People needed

10

Starts

2024-09-09

Expected to finish

2027-12-30

Last updated by the study team

2026-04-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 1) Adult patients (>18 years)
• 2) Have moderate to severe cGVHD based on their oncology clinician assessment as documented in the electronic health record.
• 3) Ability to comprehend and speak English, and to read and respond to questions in English
• Please note that this is a proof-of-concept study, and we only include patients who comprehend, read, and respond to questions in English since the study instruments are all available in English. However, as we have done in prior studies, we will expand the population in a future efficacy trial.

You may not qualify if…

• 1) Patients with acute or unstable psychiatric or cognitive conditions which the treating clinicians believe prohibits informed consent or compliance with study procedures
• 2) Patients who have already consulted or are currently consulting palliative care

Where it is running

• Massachusetts General Hospital (MGH) — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.